New Leaf Venture Overview
- Investor Type
- Venture Capital
- Status
- Active
- Professionals
- 3
- Investments
- 243
- Portfolio
- 28
- Exits
- 159
New Leaf Venture General Information
Description
Founded in 2005, New Leaf Venture Partners is a venture capital investment firm based in New York, New York. The firm is focused on healthcare technology-focused and seeks to invest in the biopharmaceutical, information convergence, medical device, biological research, life science tool and infrastructure sectors.
Contact Information
Website
www.nlvpartners.com
Year Founded
2005
Investor Status
Actively Seeking New Investments
Trade Association
National Venture Capital Association (NVCA)
Primary Investor Type
Venture Capital
Other Investor Types
Growth/Expansion
Primary Office
- 420 Lexington Avenue
- Suite 408
- New York, NY 10170
- United States
+1 (646) 000-0000
New Leaf Venture Investments (243)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Neurana Pharmaceuticals | 16-Nov-2021 | Later Stage VC | 0000 | Drug Discovery | Generating Revenue | 000000 0000 |
| 0000 000000000 | 20-Aug-2021 | 00000 00000 | 0000 | Drug Discovery | Generating Revenue/Not Profitable | |
| 0000000 | 30-Jul-2021 | 00000 00000 | 00.000 | Decision/Risk Analysis | Generating Revenue | |
| 0000000 | 21-Jun-2021 | 00000 00000 | 0000 | Decision/Risk Analysis | Generating Revenue | 00000 00000 |
| 00000 | 26-May-2021 | 00000 00000 | 00000 | Other Healthcare Technology Systems | Generating Revenue | |
| 00000 000000000000 | 20-Apr-2021 | 00000 00000 | 000.00 | Biotechnology | Profitable | 000000 0000 |
| 0000000000000 | 10-Mar-2021 | 00000 00000 | 00000 | Enterprise Systems (Healthcare) | Generating Revenue | 00000 00000 |
| 0000 000000000 | 08-Jan-2021 | 00000 00000 | 0000 | Drug Discovery | Generating Revenue/Not Profitable | |
| Edgewise Therapeutics | 08-Dec-2020 | Later Stage VC | 0000 | Drug Discovery | Generating Revenue/Not Profitable | |
| TigerConnect | 18-Sep-2020 | Later Stage VC | 0000 | Enterprise Systems (Healthcare) | Generating Revenue | 00000 00000 |
New Leaf Venture Exits (159)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| DiCE Molecules | 15-Sep-2021 | IPO | 00000 |
| 000000000 | 02-Sep-2021 | 0000000 000000 | 000.00 |
| 00000000 | 29-Jul-2021 | 000 | 000.00 |
| 00000000000 | 01-Apr-2021 | 000000000 00000000 | |
| 00000000 000000000 | 26-Mar-2021 | 000 | 00000 |
| 0000000 000 | 22-Jan-2021 | 000000 0000000000 | 00000 |
| 00000 000000000000 | 08-Jan-2021 | 000000 0000000000 | 0000 |
| 0000000 | 06-Nov-2020 | 000 00 00000000 | |
| Intarcia | 01-Nov-2020 | Bankruptcy: Liquidation | |
| Iterum Therapeutics | 26-Oct-2020 | Public Investment 2nd Offering | 000.00 |
New Leaf Venture Fund Performance
| Fund Name | Vintage | Size | Dry Powder | DPI | RVPI | TVPI | IRR |
|---|
This information is available in the PitchBook Platform. To explore New Leaf Venture‘s full profile, request access.
Request a free trialNew Leaf Venture Investments by Industry, Year, and Region
Investments by Industry
Investments by Year
Investments by Region
PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.
Request a free trialNew Leaf Venture Team (47)
| Name | Title | Deals | Funds | Boards | Office |
|---|---|---|---|---|---|
| Craig Slutzkin | Chief Financial Officer & Chief Operating Officer | New York, NY | |||
| James Niedel Ph.D | Venture Partner | 00 | 0 | New York, NY | |
| Ronald Hunt | Co-Founder & Managing Director | 00 | 0 | 0 | New York, NY |
| Vijay Lathi | Co-Founder & Managing Director | 00 | 0 | 0 | Menlo Park, CA |
| Christy Chuang-Stein | Advisor | New York, NY |
New Leaf Venture Co-Investors (168)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| OrbiMed | 8 | 0 |
|
|
|
| Canaan Partners | 0 | 0 |
|
|
|
| Novo Holdings | 0 | 0 |
|
|
|
| Polaris Partners | 0 | 0 |
|
|
|
| RA Capital Management | 0 | 0 |
|
|